It’s not just doorways that make us forget what we came for in the next room

It’s not just doorways that make us forget what we came for in the next room

Imagine you’re in the middle of watching a riveting episode of your favorite TV show. You deci...
read more
Why it's OK if your version of self-care doesn't look Instagram-perfect

Why it's OK if your version of self-care doesn't look Instagram-perfect

The reality of living through a pandemic means sel...
read more
Could the UK have avoided its terrible Covid-19 death toll?

Could the UK have avoided its terrible Covid-19 death toll?

How did Britain end up with the worst Covid-19 dea...
read more
It's a … ! MAFS' Ashley Petta and Anthony D'Amico Welcome 2nd Child

It's a … ! MAFS' Ashley Petta and Anthony D'Amico Welcome 2nd Child

Girl gang! Ashley Petta gave birth on Wednesday, F...
read more
How a Bounty of Vaccines Flooded a Small Hospital and Its Nearby College

How a Bounty of Vaccines Flooded a Small Hospital and Its Nearby College

When administrators at Hillsdale College, a conser...
read more
Mexico says it’s OK with getting less Pfizer vaccine for now

Mexico says it’s OK with getting less Pfizer vaccine for now

President Andrés Manuel López Obrador said Sunda...
read more
LIVE UPDATES: Florida confirms its first case of new coronavirus strain

LIVE UPDATES: Florida confirms its first case of new coronavirus strain

Will vaccines still work on new coronavirus strain...
read more
Whether it’s 2020 or Baby Shark, study offers clues on how to stop thinking about it

Whether it’s 2020 or Baby Shark, study offers clues on how to stop thinking about it

“Let it go.” “Think about someth...
read more
COVID-19 immunity and reinfection: Why it’s still essential to take precautions

COVID-19 immunity and reinfection: Why it’s still essential to take precautions

With some viruses, once you have been infected and...
read more
INOVIO Doses First Subject in Phase 2 Segment of its INNOVATE Phase 2/3 Clinical Trial for INO-4800, its DNA Medicine to Prevent COVID-19

INOVIO Doses First Subject in Phase 2 Segment of its INNOVATE Phase 2/3 Clinical Trial for INO-4800, its DNA Medicine to Prevent COVID-19

PLYMOUTH MEETING, Pa., Dec. 7, 2020 /PRNewswire/ &...
read more